Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
Best Practices in the Art and Science of Clinical Documentation Improvement.

Journal of AHIMA

Arrowood D, Bailey-Woods L, Easterling S, Endicott M, Love T, McDonald L, Rhinehart E, Wieczorek M.
PMID: 26642623
J AHIMA. 2015 Jul;86(7):46-50.

No abstract available.

Cite
Arrowood D, Bailey-Woods L, Easterling S, et al. Best Practices in the Art and Science of Clinical Documentation Improvement. J AHIMA. 2015;86(7):46-50
Arrowood, D., Bailey-Woods, L., Easterling, S., Endicott, M., Love, T., McDonald, L., Rhinehart, E., & Wieczorek, M. (2015). Best Practices in the Art and Science of Clinical Documentation Improvement. Journal of AHIMA, 86(7), 46-50.
Arrowood, Danita, et al. "Best Practices in the Art and Science of Clinical Documentation Improvement." Journal of AHIMA vol. 86,7 (2015): 46-50.
Arrowood D, Bailey-Woods L, Easterling S, Endicott M, Love T, McDonald L, Rhinehart E, Wieczorek M. Best Practices in the Art and Science of Clinical Documentation Improvement. J AHIMA. 2015 Jul;86(7):46-50. PMID: 26642623.
Copy Download .nbib Format: NLM
Draft Genome Sequences from Cyclospora cayetanensis Oocysts Purified from a Human Stool Sample.

Genome announcements

Qvarnstrom Y, Wei-Pridgeon Y, Li W, Nascimento FS, Bishop HS, Herwaldt BL, Moss DM, Nayak V, Srinivasamoorthy G, Sheth M, Arrowood MJ.
PMID: 26586880
Genome Announc. 2015 Nov 19;3(6). doi: 10.1128/genomeA.01324-15.

The parasite Cyclospora cayetanensis causes foodborne diarrheal illness. Here, we report draft genome sequences obtained from C. cayetanensis oocysts purified from a human stool sample. The genome assembly consists of 865 contigs with a total length of 44,563,857 bases....

Cite
Qvarnstrom Y, Wei-Pridgeon Y, Li W, et al. Draft Genome Sequences from Cyclospora cayetanensis Oocysts Purified from a Human Stool Sample. Genome Announc. 2015;3(6)doi: 10.1128/genomeA.01324-15.
Qvarnstrom, Y., Wei-Pridgeon, Y., Li, W., Nascimento, F. S., Bishop, H. S., Herwaldt, B. L., Moss, D. M., Nayak, V., Srinivasamoorthy, G., Sheth, M., & Arrowood, M. J. (2015). Draft Genome Sequences from Cyclospora cayetanensis Oocysts Purified from a Human Stool Sample. Genome announcements, 3(6), . https://doi.org/10.1128/genomeA.01324-15
Qvarnstrom, Yvonne, et al. "Draft Genome Sequences from Cyclospora cayetanensis Oocysts Purified from a Human Stool Sample." Genome announcements vol. 3,6 (2015). doi: https://doi.org/10.1128/genomeA.01324-15
Qvarnstrom Y, Wei-Pridgeon Y, Li W, Nascimento FS, Bishop HS, Herwaldt BL, Moss DM, Nayak V, Srinivasamoorthy G, Sheth M, Arrowood MJ. Draft Genome Sequences from Cyclospora cayetanensis Oocysts Purified from a Human Stool Sample. Genome Announc. 2015 Nov 19;3(6). doi: 10.1128/genomeA.01324-15. PMID: 26586880; PMCID: PMC4653782.
Copy Download .nbib Format: NLM
Treatment Issues in Adolescent Substance Use and Addictions: Options, Outcome, Effectiveness, Reimbursement, and Admission Criteria.

Adolescent medicine (Philadelphia, Pa.)

Hoffmann NG, Mee-Lee D, Arrowood AA.
PMID: 10356221
Adolesc Med. 1993 Jun;4(2):371-390.

Cost-reduction strategies and a lack of overall perspective have created a potentially dangerous climate for the treatment of the various forms of adolescent substance abuse. The authors argue for a holistic approach that focuses on demographics, family issues, school...

Cite
Hoffmann NG, Mee-Lee D, Arrowood AA. Treatment Issues in Adolescent Substance Use and Addictions: Options, Outcome, Effectiveness, Reimbursement, and Admission Criteria. Adolesc Med. 1993;4(2):371-390
Hoffmann, N. G., Mee-Lee, D., & Arrowood, A. A. (1993). Treatment Issues in Adolescent Substance Use and Addictions: Options, Outcome, Effectiveness, Reimbursement, and Admission Criteria. Adolescent medicine (Philadelphia, Pa.), 4(2), 371-390.
Hoffmann, et al. "Treatment Issues in Adolescent Substance Use and Addictions: Options, Outcome, Effectiveness, Reimbursement, and Admission Criteria." Adolescent medicine (Philadelphia, Pa.) vol. 4,2 (1993): 371-390.
Hoffmann NG, Mee-Lee D, Arrowood AA. Treatment Issues in Adolescent Substance Use and Addictions: Options, Outcome, Effectiveness, Reimbursement, and Admission Criteria. Adolesc Med. 1993 Jun;4(2):371-390. PMID: 10356221.
Copy Download .nbib Format: NLM
Operator Radiation Exposure in PTCA: Comparison of Radial and Femoral Approaches.

The Journal of invasive cardiology

Mann JT, Cubeddu G, Arrowood M.
PMID: 10785782
J Invasive Cardiol. 1996;8:22D-25D.

In order to evaluate the radiation risk associated with PTCA from the right radial approach, operator radiation exposure was prospectively measured in 138 patients (pts) undergoing PTCA from the radial artery approach and in 126 patients from the femoral...

Cite
Mann JT, Cubeddu G, Arrowood M. Operator Radiation Exposure in PTCA: Comparison of Radial and Femoral Approaches. J Invasive Cardiol. 1996;8:22D-25D
Mann, J. T., Cubeddu, G., & Arrowood, M. (1996). Operator Radiation Exposure in PTCA: Comparison of Radial and Femoral Approaches. The Journal of invasive cardiology, 822D-25D.
Mann, et al. "Operator Radiation Exposure in PTCA: Comparison of Radial and Femoral Approaches." The Journal of invasive cardiology vol. 8 (1996): 22D-25D.
Mann JT, Cubeddu G, Arrowood M. Operator Radiation Exposure in PTCA: Comparison of Radial and Femoral Approaches. J Invasive Cardiol. 1996;8:22D-25D. PMID: 10785782.
Copy Download .nbib Format: NLM
Inactivation of Cryptosporidium parvum Oocysts and Clostridium perfringens Spores by a Mixed-Oxidant Disinfectant and by Free Chlorine.

Applied and environmental microbiology

Venczel LV, Arrowood M, Hurd M, Sobsey MD.
PMID: 16535745
Appl Environ Microbiol. 1997 Nov;63(11):4625. doi: 10.1128/aem.63.11.4625-4625b.1997.

Volume 63, no. 4, p. 1600: The caption to Table 2 should read as follows: "Inactivation of Clostridium perfringens spores by 5-mg/liter doses of mixed oxidants or free chlorine in buffer at pH 7 at 25(deg)C." [This corrects the...

Cite
Venczel LV, Arrowood M, Hurd M, et al. Inactivation of Cryptosporidium parvum Oocysts and Clostridium perfringens Spores by a Mixed-Oxidant Disinfectant and by Free Chlorine. Appl Environ Microbiol. 1997;63(11):4625doi: 10.1128/aem.63.11.4625-4625b.1997.
Venczel, L. V., Arrowood, M., Hurd, M., & Sobsey, M. D. (1997). Inactivation of Cryptosporidium parvum Oocysts and Clostridium perfringens Spores by a Mixed-Oxidant Disinfectant and by Free Chlorine. Applied and environmental microbiology, 63(11), 4625. https://doi.org/10.1128/aem.63.11.4625-4625b.1997
Venczel, L V, et al. "Inactivation of Cryptosporidium parvum Oocysts and Clostridium perfringens Spores by a Mixed-Oxidant Disinfectant and by Free Chlorine." Applied and environmental microbiology vol. 63,11 (1997): 4625. doi: https://doi.org/10.1128/aem.63.11.4625-4625b.1997
Venczel LV, Arrowood M, Hurd M, Sobsey MD. Inactivation of Cryptosporidium parvum Oocysts and Clostridium perfringens Spores by a Mixed-Oxidant Disinfectant and by Free Chlorine. Appl Environ Microbiol. 1997 Nov;63(11):4625. doi: 10.1128/aem.63.11.4625-4625b.1997. PMID: 16535745; PMCID: PMC1389301.
Copy Download .nbib Format: NLM
Critique of "A Study of the Deaths Associated with Anesthesia and Surgery".

Annals of surgery

Abajian J, Arrowood JG, Barrett RH, Dwyer CS, Eversole UH, Fine JH, Hand LV, Howrie WC, Marcus PS, Martin SJ, Nicholson MJ, Saklad E, Saklad M, Sellman P, Smith RM, Woodbridge PD.
PMID: 17859561
Ann Surg. 1955 Jul;142(1):138-41. doi: 10.1097/00000658-195507000-00021.

No abstract available.

Cite
Abajian J, Arrowood JG, Barrett RH, et al. Critique of "A Study of the Deaths Associated with Anesthesia and Surgery". Ann Surg. 1955;142(1):138-41doi: 10.1097/00000658-195507000-00021.
Abajian, J., Arrowood, J. G., Barrett, R. H., Dwyer, C. S., Eversole, U. H., Fine, J. H., Hand, L. V., Howrie, W. C., Marcus, P. S., Martin, S. J., Nicholson, M. J., Saklad, E., Saklad, M., Sellman, P., Smith, R. M., & Woodbridge, P. D. (1955). Critique of "A Study of the Deaths Associated with Anesthesia and Surgery". Annals of surgery, 142(1), 138-41. https://doi.org/10.1097/00000658-195507000-00021
Abajian, J, et al. "Critique of "A Study of the Deaths Associated with Anesthesia and Surgery"." Annals of surgery vol. 142,1 (1955): 138-41. doi: https://doi.org/10.1097/00000658-195507000-00021
Abajian J, Arrowood JG, Barrett RH, Dwyer CS, Eversole UH, Fine JH, Hand LV, Howrie WC, Marcus PS, Martin SJ, Nicholson MJ, Saklad E, Saklad M, Sellman P, Smith RM, Woodbridge PD. Critique of "A Study of the Deaths Associated with Anesthesia and Surgery". Ann Surg. 1955 Jul;142(1):138-41. doi: 10.1097/00000658-195507000-00021. PMID: 17859561; PMCID: PMC1465051.
Copy Download .nbib Format: NLM
Micromachining on and of Transparent Polymers for Patterning Electrodes and Growing Electrically Active Cells for Biosensor Applications.

Micromachines

Karnati C, Aguilar R, Arrowood C, Ross J, Rajaraman S.
PMID: 30400441
Micromachines (Basel). 2017 Aug 15;8(8). doi: 10.3390/mi8080250.

We report on microfabrication and assembly process development on transparent, biocompatible polymers for patterning electrodes and growing electrically active cells for

Cite
Karnati C, Aguilar R, Arrowood C, et al. Micromachining on and of Transparent Polymers for Patterning Electrodes and Growing Electrically Active Cells for Biosensor Applications. Micromachines (Basel). 2017;8(8)doi: 10.3390/mi8080250.
Karnati, C., Aguilar, R., Arrowood, C., Ross, J., & Rajaraman, S. (2017). Micromachining on and of Transparent Polymers for Patterning Electrodes and Growing Electrically Active Cells for Biosensor Applications. Micromachines, 8(8), . https://doi.org/10.3390/mi8080250
Karnati, Chandana, et al. "Micromachining on and of Transparent Polymers for Patterning Electrodes and Growing Electrically Active Cells for Biosensor Applications." Micromachines vol. 8,8 (2017). doi: https://doi.org/10.3390/mi8080250
Karnati C, Aguilar R, Arrowood C, Ross J, Rajaraman S. Micromachining on and of Transparent Polymers for Patterning Electrodes and Growing Electrically Active Cells for Biosensor Applications. Micromachines (Basel). 2017 Aug 15;8(8). doi: 10.3390/mi8080250. PMID: 30400441; PMCID: PMC6190309.
Copy Download .nbib Format: NLM
Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020.

The Journal of infectious diseases

Barratt J, Ahart L, Rice M, Houghton K, Richins T, Cama V, Arrowood M, Qvarnstrom Y, Straily A.
PMID: 34606577
J Infect Dis. 2021 Oct 04; doi: 10.1093/infdis/jiab495. Epub 2021 Oct 04.

Cyclosporiasis is a diarrheal illness caused by the food-borne parasite Cyclospora cayetanensis. Annually reported cases have been increasing in the United States prompting development of genotyping tools to aid cluster detection. A recently developed Cyclospora genotyping system based on...

Cite
Barratt J, Ahart L, Rice M, et al. Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020. J Infect Dis. 2021;doi: 10.1093/infdis/jiab495.
Barratt, J., Ahart, L., Rice, M., Houghton, K., Richins, T., Cama, V., Arrowood, M., Qvarnstrom, Y., & Straily, A. (2021). Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020. The Journal of infectious diseases, . https://doi.org/10.1093/infdis/jiab495
Barratt, Joel, et al. "Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020." The Journal of infectious diseases vol. (2021). doi: https://doi.org/10.1093/infdis/jiab495
Barratt J, Ahart L, Rice M, Houghton K, Richins T, Cama V, Arrowood M, Qvarnstrom Y, Straily A. Genotyping Cyclospora cayetanensis from multiple outbreak clusters with an emphasis on a cluster linked to bagged salad mix - United States, 2020. J Infect Dis. 2021 Oct 04; doi: 10.1093/infdis/jiab495. Epub 2021 Oct 04. PMID: 34606577.
Copy Download .nbib Format: NLM
Transradial Coronary Stenting: A United States Experience.

The Journal of invasive cardiology

Schneider JE, Mann T, Cubeddu MG, Arrowood ME.
PMID: 10762962
J Invasive Cardiol. 1997 Nov;9(9):569-574.

Coronary stenting is associated with increased vascular complications and prolonged length of stay compared to balloon angioplasty. One strategy to address these concerns is performing the coronary stent procedure via the radial artery access site. The current study reviews...

Cite
Schneider JE, Mann T, Cubeddu MG, et al. Transradial Coronary Stenting: A United States Experience. J Invasive Cardiol. 1997;9(9):569-574
Schneider, J. E., Mann, T., Cubeddu, M. G., & Arrowood, M. E. (1997). Transradial Coronary Stenting: A United States Experience. The Journal of invasive cardiology, 9(9), 569-574.
Schneider, et al. "Transradial Coronary Stenting: A United States Experience." The Journal of invasive cardiology vol. 9,9 (1997): 569-574.
Schneider JE, Mann T, Cubeddu MG, Arrowood ME. Transradial Coronary Stenting: A United States Experience. J Invasive Cardiol. 1997 Nov;9(9):569-574. PMID: 10762962.
Copy Download .nbib Format: NLM
Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice.

Frontiers in microbiology

Sonzogni-Desautels K, Renteria AE, Camargo FV, Di Lenardo TZ, Mikhail A, Arrowood MJ, Fortin A, Ndao M.
PMID: 26441906
Front Microbiol. 2015 Sep 23;6:973. doi: 10.3389/fmicb.2015.00973. eCollection 2015.

Cryptosporidium parvum is a species of protozoa that causes cryptosporidiosis, an intestinal disease affecting many mammals including humans. Typically, in healthy individuals, cryptosporidiosis is a self-limiting disease. However, C. parvum can cause a severe and persistent infection that can...

Cite
Sonzogni-Desautels K, Renteria AE, Camargo FV, et al. Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice. Front Microbiol. 2015;6:973doi: 10.3389/fmicb.2015.00973.
Sonzogni-Desautels, K., Renteria, A. E., Camargo, F. V., Di Lenardo, T. Z., Mikhail, A., Arrowood, M. J., Fortin, A., & Ndao, M. (2015). Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice. Frontiers in microbiology, 6973. https://doi.org/10.3389/fmicb.2015.00973
Sonzogni-Desautels, Karine, et al. "Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice." Frontiers in microbiology vol. 6 (2015): 973. doi: https://doi.org/10.3389/fmicb.2015.00973
Sonzogni-Desautels K, Renteria AE, Camargo FV, Di Lenardo TZ, Mikhail A, Arrowood MJ, Fortin A, Ndao M. Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice. Front Microbiol. 2015 Sep 23;6:973. doi: 10.3389/fmicb.2015.00973. eCollection 2015. PMID: 26441906; PMCID: PMC4585137.
Copy Download .nbib Format: NLM
Diminished Cortical Excitation and Elevated Inhibition During Perceptual Impairments in a Mouse Model of Autism.

Cerebral cortex (New York, N.Y. : 1991)

Del Rosario J, Speed A, Arrowood H, Motz C, Pardue M, Haider B.
PMID: 33677512
Cereb Cortex. 2021 Jun 10;31(7):3462-3474. doi: 10.1093/cercor/bhab025.

Sensory impairments are a core feature of autism spectrum disorder (ASD). These impairments affect visual perception and have been hypothesized to arise from imbalances in cortical excitatory and inhibitory activity. There is conflicting evidence for this hypothesis from several...

Cite
Del Rosario J, Speed A, Arrowood H, et al. Diminished Cortical Excitation and Elevated Inhibition During Perceptual Impairments in a Mouse Model of Autism. Cereb Cortex. 2021;31(7):3462-3474doi: 10.1093/cercor/bhab025.
Del Rosario, J., Speed, A., Arrowood, H., Motz, C., Pardue, M., & Haider, B. (2021). Diminished Cortical Excitation and Elevated Inhibition During Perceptual Impairments in a Mouse Model of Autism. Cerebral cortex (New York, N.Y. : 1991), 31(7), 3462-3474. https://doi.org/10.1093/cercor/bhab025
Del Rosario, Joseph, et al. "Diminished Cortical Excitation and Elevated Inhibition During Perceptual Impairments in a Mouse Model of Autism." Cerebral cortex (New York, N.Y. : 1991) vol. 31,7 (2021): 3462-3474. doi: https://doi.org/10.1093/cercor/bhab025
Del Rosario J, Speed A, Arrowood H, Motz C, Pardue M, Haider B. Diminished Cortical Excitation and Elevated Inhibition During Perceptual Impairments in a Mouse Model of Autism. Cereb Cortex. 2021 Jun 10;31(7):3462-3474. doi: 10.1093/cercor/bhab025. PMID: 33677512; PMCID: PMC8525192.
Copy Download .nbib Format: NLM
Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS.

Investigational new drugs

Kenney C, Kunst T, Webb S, Christina D, Arrowood C, Steinberg SM, Mettu NB, Kim EJ, Rudloff U.
PMID: 33405090
Invest New Drugs. 2021 Jun;39(3):821-828. doi: 10.1007/s10637-020-01044-8. Epub 2021 Jan 06.

Background Preclinical evidence has suggested that a subset of pancreatic cancers with the G12R mutational isoform of the KRAS oncogene is more sensitive to MAPK pathway blockade than pancreatic tumors with other KRAS isoforms. We conducted a biomarker-driven trial...

Cite
Kenney C, Kunst T, Webb S, et al. Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS. Invest New Drugs. 2021;39(3):821-828doi: 10.1007/s10637-020-01044-8.
Kenney, C., Kunst, T., Webb, S., Christina, D., Arrowood, C., Steinberg, S. M., Mettu, N. B., Kim, E. J., & Rudloff, U. (2021). Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS. Investigational new drugs, 39(3), 821-828. https://doi.org/10.1007/s10637-020-01044-8
Kenney, Cara, et al. "Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS." Investigational new drugs vol. 39,3 (2021): 821-828. doi: https://doi.org/10.1007/s10637-020-01044-8
Kenney C, Kunst T, Webb S, Christina D, Arrowood C, Steinberg SM, Mettu NB, Kim EJ, Rudloff U. Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS. Invest New Drugs. 2021 Jun;39(3):821-828. doi: 10.1007/s10637-020-01044-8. Epub 2021 Jan 06. PMID: 33405090; PMCID: PMC8068685.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries